• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nanomedicine: Nanotechnology, Biology and Medicine - Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protectiv

tetano

Editor, Senior Moderator
Nanomedicine: Nanotechnology, Biology and Medicine

Available online 27 August 2013

In Press, Accepted Manuscript ? Note to users
Cover image
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines

Li Wanga,
Annie Hessb,
Timothy Z. Changb,
Ying-Chun Wanga,
Julie A. Championb, Corresponding author contact information, E-mail the corresponding author,
Richard W. Compansa, Corresponding author contact information, E-mail the corresponding author,
Bao-Zhong Wanga, Corresponding author contact information, E-mail the corresponding author

a Department of Microbiology and Immunology, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia
b Georgia Institute of Technology, School of Chemical & Biomolecular Engineering, Atlanta, Georgia

Abstract

Influenza vaccines with broad cross-protection are urgently needed. The highly conserved ectodomain of the influenza matrix protein 2 (M2e) can be a promising candidate if its low immunogenicity was overcome. In this study, we generated protein nanoclusters self-assembled from conformation-stabilized M2e tetramers (tM2e) to improve its immunogenicity. The resulting nanoclusters showed an average hydrodynamic diameter of 268 nm. Vaccination with the nanoclusters by an intranasal route elicited high levels of serum antigen-specific IgG in mice (approximately 100-fold higher than that obtained with soluble tM2e), as well as antigen-specific T cell and mucosal antibody responses. The immunity conferred complete protection against lethal challenge with homo- as well as heterosubtypic viruses. These results demonstrate that nanoclusters assembled from conformation-stabilized M2e are promising as a potential universal influenza A vaccine. Self-assembly into nanoclusters represents a novel approach for increasing the immunogenicity of vaccine antigens.

http://www.sciencedirect.com/science/article/pii/S1549963413003651
 
Back
Top Bottom